Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance

被引:13
|
作者
Molina, Kyle C. [1 ,2 ,3 ]
Hall, Scott T. [2 ]
Barletta, Jeffrey F. [3 ]
Mangram, Alicia J. [4 ,5 ]
Dzandu, James K. [4 ,5 ]
Huang, Vanthida [3 ]
机构
[1] Scripps Mercy Hosp, Dept Pharm, San Diego, CA USA
[2] HonorHlth John C Lincoln Med Ctr, Dept Pharm, Phoenix, AZ USA
[3] Midwestern Univ, Coll Pharm Glendale, Dept Pharm Practice, 19555 N 59th Ave, Glendale, AZ 85308 USA
[4] HonorHlth John C Lincoln Med Ctr, Trauma Serv, Phoenix, AZ USA
[5] HonorHlth John C Lincoln Med Ctr, Acute Care Surg, Phoenix, AZ USA
关键词
augmented renal clearance; therapeutic drug monitoring; trauma critical care; vancomycin; CRITICALLY-ILL PATIENTS; RECOMMENDATIONS;
D O I
10.1089/sur.2019.026
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The Augmented Renal Clearance in Trauma Intensive Care (ARCTIC) scoring system is a validated system to predict augmented renal clearance in trauma patients. This study examined the ability of the ARCTIC score to identify patients at risk for subtherapeutic vancomycin trough concentrations relative to estimated creatinine clearance (eCrCl) alone. Methods: Trauma patients admitted to the intensive care unit from September 2012 to December 2017 who received vancomycin and had a vancomycin trough concentration recorded were included. Patients were excluded if their serum creatinine concentration was >1.3 mg/dL, if they had received vancomycin doses <30 mg/kg per day, an improperly timed trough concentration measurement, or renal replacement therapy. The primary endpoint was an initial subtherapeutic vancomycin trough concentration (<10 mg/L). Classification and regression tree (CART) analysis was used to identify thresholds for the ARCTIC score and other continuous data where subtherapeutic troughs were more common. A step-wise logistic regression analysis was performed to control for confounders for subtherapeutic troughs whereby inclusion of ARCTIC was modeled sequentially after eCrCl. Results: A total of 119 patients with a mean age of 42 +/- 17 years and eCrCl 142 +/- 39 mL/min met the inclusion criteria. The mean daily vancomycin dose was 44 +/- 9 mg/kg, and the incidence of subtherapeutic trough concentration was 46%. The CART analysis identified two variables creating three groups where subtherapeutic trough concentrations differed: eCrCl >105 mL/min and ARCTIC score >= 7, eCrCl >105 mL/min and ARCTIC score <7, and eCrCl <= 105 mL/min. The base logistic regression model identified eCrCl >105 mL/min and pelvic fracture as risk factors for subtherapeutic trough values. The final model included the addition of ARCTIC score >= 7, which improved the model significantly (p = 0.009). Predictors of subtherapeutic trough concentrations were (odds ratio [95% confidence interval]): eCrCl >105 mL/min (6.5 [1.66-25.07]), ARCTIC score >= 7 (3.26 [1.31-8.09]), and pelvic fracture (4.36 [1.27-14.93]). Conclusion: The ARCTIC score is useful when applied in conjunction with eCrCl. Patients with a eCrCl >105 mL/min and an ARCTIC score >= 7 may require a more aggressive dosing strategy.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 50 条
  • [41] ARCTIC SCORE & ARC PREDICTOR TO IDENTIFY AUGMENTED RENAL CLEARANCE IN CRITICALLY ILL TRAUMA PATIENTS
    Farrar, Julie
    Swanson, Joe
    Hudson, Joanna
    Byerly, Saskya
    Filiberto, Dina
    Dickerson, Roland
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [42] Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin
    Hirai, Keita
    Ishii, Hidetoshi
    Shimoshikiryo, Takayuki
    Shimomura, Tatsuki
    Tsuji, Daiki
    Inoue, Kazuyuki
    Kadoiri, Toshihiko
    Itoh, Kunihiko
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (06) : 706 - 710
  • [43] Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance
    Belabbas, Tassadit
    Yamada, Takaaki
    Egashira, Nobuaki
    Hirota, Takeshi
    Suetsugu, Kimitaka
    Mori, Yasuo
    Kato, Koji
    Akashi, Koichi
    Ieiri, Ichiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (04) : 391 - 400
  • [44] Augmented Renal Clearance in Severe Infections-An Important Consideration in Vancomycin Dosing: A Narrative Review
    Xiao, Qile
    Zhang, Hainan
    Wu, Xiaomei
    Qu, Jian
    Qin, Lixia
    Wang, Chunyu
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
    Udy, Andrew A.
    Roberts, Jason A.
    Boots, Robert J.
    Paterson, David L.
    Lipman, Jeffrey
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (01) : 1 - 16
  • [46] A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
    He, Juan
    Yang, Zhi-Tao
    Qian, Xian
    Zhao, Bing
    Mao, En-Qiang
    Chen, Er-Zhen
    Bian, Xiao-Lan
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2166 - 2171
  • [47] The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients
    Tesfamariam, Novel Solomon
    Aboelezz, Asma
    Mahmoud, Sherif Hanafy
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [48] Augmented Renal Vancomycin Clearance in Cancer Patients: A Case Report and Review of the Literature
    Curth, Harald-Morten
    Pelc, Agnes
    Kuetting, Fabian
    Steffen, Hans-Michael
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (04) : 182 - 184
  • [49] CONTINUOUS VERSUS INTERMITTENT VANCOMYCIN INFUSION IN ICU PATIENTS WITH AUGMENTED RENAL CLEARANCE
    Keil, Elizabeth
    Diep, Calvin
    Meng, Lina
    Ran, Ran
    Lorenzo, Javier
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 375 - 375
  • [50] Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage
    Casey C. May
    Shaily Arora
    Sara E. Parli
    Justin F. Fraser
    Melissa Thompson Bastin
    Aaron M. Cook
    [J]. Neurocritical Care, 2015, 23 : 374 - 379